Newman Smith senior safety, Kalen Berry, was sidelined by cancer last year. He is looking to make a comeback this year.
A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.
This month many people are thinking ‘pink’ for breast cancer awareness, but for survivors, the fight is anything but pretty. Now local survivors have taken to the internet to paint another picture of breast cancer.
The results of a long-term major federal study that was done in Texas is easing worries about the safety of a hormone-blocking drug that can lower a man’s chances of developing prostate cancer.
Hair loss is one of chemotherapy’s most noticeable and despised side effects. Now U.S. researchers are about to put an experimental hair-preserving treatment to a rigorous test.
The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
The Food and Drug Administration has expanded approval of Johnson & Johnson’s prostate cancer pill Zytiga for men with an earlier stage of the disease.
It’s shock enough to be diagnosed with cancer. But, a Grand Prairie man says he was terrified when doctors told him he had breast cancer.
A senior at Boles High School, near Quinlan, is battling a rare form of cancer. So, the entire school surprised him with a day he and his classmates will never forget.
Breast cancer survivors are finding yoga can help them relax and recover after treatment.
It was a crushing blow for Linda Diaz. She didn’t know how she was going to tell her 12-year-old son, Christopher, he had cancer. Just days later she had to try and explain why someone burglarized their home. Burglars
Diane Aulger was two weeks from her due date when she and her husband decided there was no time to wait: Mark Aulger had days to live, and he wanted to see his child.